首页> 外国专利> (+)-CYANIDAN-3-OL((+)-CATECHIN)DERIVATIVES:PHARMACEUTICAL COMPOSITIONS

(+)-CYANIDAN-3-OL((+)-CATECHIN)DERIVATIVES:PHARMACEUTICAL COMPOSITIONS

机译:(+)-CYANIDAN-3-OL((+)-儿茶素)衍生物:药物成分

摘要

Pharmaceutical preparations containing (+)-cyanidan-3-ol derivatives of the formula I IMAGE (I) wherein R' and R'' are hydrogen, an unsubstituted or substituted hydrocarbon radical, or heterocyclic radical, halogen, formyl, free or functionally modified carboxyl, free or etherified or esterified hydroxyl, free, etherified or oxidized mercapto, unsubstituted or substituted sulfamoyl, acyl or unsubstituted or substituted amino, where however R' and R'' cannot both be hydrogen simultaneously, and R1, R2, R3, R4 and R5 are each hydrogen or an unsubstituted or substituted hydrocarbon radical, and R2 and R3 together can also be an unsubstituted or substituted methylene group, and R1 also an acyl group or an amidated carboxyl group; and therapeutically applicable salts of these compounds, as well as new compounds of these preparations. These pharmaceutical preparations are particularly valuable for treating liver and venous diseases.
机译:包含式(I)的(+)-氰基-3-醇衍生物的药物制剂(I)其中R'和R''为氢,未取代或取代的烃基或杂环基,卤素,甲酰基,游离基或功能改性的羧基,游离或醚化或酯化的羟基,游离,醚化或氧化的巯基,未取代或取代的氨磺酰基,酰基或未取代或取代的氨基,但是R'和R''不能同时为氢,R1,R2,R3 ,R 4和R 5各自为氢或未取代或取代的烃基,并且R 2和R 3一起也可以为未取代或取代的亚甲基,并且R 1也是酰基或酰胺化的羧基;这些化合物的盐和可治疗的盐,以及这些制剂的新化合物。这些药物制剂对于治疗肝和静脉疾病特别有价值。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号